{"id":62962,"date":"2026-04-13T13:44:41","date_gmt":"2026-04-13T05:44:41","guid":{"rendered":"https:\/\/flcube.com\/?p=62962"},"modified":"2026-04-13T13:44:42","modified_gmt":"2026-04-13T05:44:42","slug":"sun-pharma-in-advanced-talks-to-acquire-organon-for-12-billion-bolstering-womens-health-portfolio","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=62962","title":{"rendered":"Sun Pharma in Advanced Talks to Acquire Organon for $12 Billion, Bolstering Women&#8217;s Health Portfolio"},"content":{"rendered":"\n<p><strong>Sun Pharmaceutical Industries Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/SUNPHARMA:NSE\">NSE: SUNPHARMA<\/a>) is in advanced negotiations to acquire <strong>Organon &amp; Co.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/OGN:NYSE\">NYSE: OGN<\/a>), a global leader in women&#8217;s health, for a reported <strong>$12 billion<\/strong>, according to sources familiar with the matter. The potential deal marks a significant strategic move by India&#8217;s largest drugmaker to expand its footprint in the high-value specialty pharmaceuticals market.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-deal-timeline-amp-status\">Deal Timeline &amp; Status<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Target Company<\/strong><\/td><td>Organon &amp; Co. (NYSE: OGN)<\/td><\/tr><tr><td><strong>Acquirer<\/strong><\/td><td>Sun Pharmaceutical Industries Ltd. (NSE: SUNPHARMA)<\/td><\/tr><tr><td><strong>Reported Deal Value<\/strong><\/td><td>USD 12 billion<\/td><\/tr><tr><td><strong>Initial Evaluation<\/strong><\/td><td>Began late November 2025<\/td><\/tr><tr><td><strong>Formal Proposal<\/strong><\/td><td>Non-binding offer submitted January 2026<\/td><\/tr><tr><td><strong>Financing Partners<\/strong><\/td><td>Mitsubishi UFJ Financial Group, Standard Chartered Bank<\/td><\/tr><tr><td><strong>Market Reaction<\/strong><\/td><td>Organon shares surged 25% on April 10, 2026<\/td><\/tr><tr><td><strong>Current Status<\/strong><\/td><td>Advanced, substantive discussions; no definitive agreement yet<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale\">Strategic Rationale<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Portfolio Diversification:<\/strong> The acquisition would instantly establish Sun Pharma as a major player in the <strong>women&#8217;s health<\/strong> sector, complementing its existing generics and specialty businesses.<\/li>\n\n\n\n<li><strong>Geographic Expansion:<\/strong> Provides Sun Pharma with a robust commercial platform and established brands in the US and other developed markets, where Organon has a strong presence.<\/li>\n\n\n\n<li><strong>Value Creation:<\/strong> Organon&#8217;s focus on therapeutic areas like contraception, menopause, and fertility aligns with long-term demographic trends, offering stable cash flows and growth potential.<\/li>\n\n\n\n<li><strong>Synergy Potential:<\/strong> Significant opportunities for cost synergies in manufacturing, supply chain, and administrative functions are anticipated.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-context-amp-implications\">Market Context &amp; Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Generics Giant&#8217;s Evolution:<\/strong> This move signals Sun Pharma&#8217;s continued shift from a pure-play generics manufacturer towards a more diversified, innovation-led specialty pharma company.<\/li>\n\n\n\n<li><strong>Women&#8217;s Health Focus:<\/strong> The deal highlights the growing investor interest in the women&#8217;s health segment, which has historically been under-invested but offers substantial unmet medical needs and pricing power.<\/li>\n\n\n\n<li><strong>Financing Scale:<\/strong> A $12 billion transaction would be one of the largest overseas acquisitions by an Indian pharmaceutical company, requiring complex cross-border financing, which Sun Pharma appears to be structuring with top-tier global banks.<\/li>\n\n\n\n<li><strong>Regulatory Scrutiny:<\/strong> Given the scale and the companies&#8217; market positions, the deal is expected to face close antitrust review in multiple jurisdictions.<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward-Looking Statements<\/strong><br>This brief is based on reports from unnamed sources. Neither Sun Pharma nor Organon has officially confirmed the existence of a definitive agreement. Any potential transaction is subject to due diligence, negotiation of final terms, board approvals, and regulatory clearances. There can be no assurance that a transaction will be completed.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sun Pharmaceutical Industries Ltd. (NSE: SUNPHARMA) is in advanced negotiations to acquire Organon &amp; Co&#8230;.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[1881,972,174,3836],"class_list":["post-62962","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-nse-sunpharma","tag-nyse-ogn","tag-organon","tag-sun-pharmaceutical-industries"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Sun Pharma in Advanced Talks to Acquire Organon for $12 Billion, Bolstering Women&#039;s Health Portfolio - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Sun Pharmaceutical Industries Ltd. (NSE: SUNPHARMA) is in advanced negotiations to acquire Organon &amp; Co. (NYSE: OGN), a global leader in women&#039;s health, for a reported $12 billion, according to sources familiar with the matter. The potential deal marks a significant strategic move by India&#039;s largest drugmaker to expand its footprint in the high-value specialty pharmaceuticals market.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=62962\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sun Pharma in Advanced Talks to Acquire Organon for $12 Billion, Bolstering Women&#039;s Health Portfolio\" \/>\n<meta property=\"og:description\" content=\"Sun Pharmaceutical Industries Ltd. (NSE: SUNPHARMA) is in advanced negotiations to acquire Organon &amp; Co. (NYSE: OGN), a global leader in women&#039;s health, for a reported $12 billion, according to sources familiar with the matter. The potential deal marks a significant strategic move by India&#039;s largest drugmaker to expand its footprint in the high-value specialty pharmaceuticals market.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=62962\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-13T05:44:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-13T05:44:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62962#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62962\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Sun Pharma in Advanced Talks to Acquire Organon for $12 Billion, Bolstering Women&#8217;s Health Portfolio\",\"datePublished\":\"2026-04-13T05:44:41+00:00\",\"dateModified\":\"2026-04-13T05:44:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62962\"},\"wordCount\":401,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"NSE: SUNPHARMA\",\"NYSE: OGN\",\"Organon\",\"Sun Pharmaceutical Industries\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=62962#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62962\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=62962\",\"name\":\"Sun Pharma in Advanced Talks to Acquire Organon for $12 Billion, Bolstering Women's Health Portfolio - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-04-13T05:44:41+00:00\",\"dateModified\":\"2026-04-13T05:44:42+00:00\",\"description\":\"Sun Pharmaceutical Industries Ltd. (NSE: SUNPHARMA) is in advanced negotiations to acquire Organon & Co. (NYSE: OGN), a global leader in women's health, for a reported $12 billion, according to sources familiar with the matter. The potential deal marks a significant strategic move by India's largest drugmaker to expand its footprint in the high-value specialty pharmaceuticals market.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62962#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=62962\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=62962#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sun Pharma in Advanced Talks to Acquire Organon for $12 Billion, Bolstering Women&#8217;s Health Portfolio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Sun Pharma in Advanced Talks to Acquire Organon for $12 Billion, Bolstering Women's Health Portfolio - Insight, China&#039;s Pharmaceutical Industry","description":"Sun Pharmaceutical Industries Ltd. (NSE: SUNPHARMA) is in advanced negotiations to acquire Organon & Co. (NYSE: OGN), a global leader in women's health, for a reported $12 billion, according to sources familiar with the matter. The potential deal marks a significant strategic move by India's largest drugmaker to expand its footprint in the high-value specialty pharmaceuticals market.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=62962","og_locale":"en_US","og_type":"article","og_title":"Sun Pharma in Advanced Talks to Acquire Organon for $12 Billion, Bolstering Women's Health Portfolio","og_description":"Sun Pharmaceutical Industries Ltd. (NSE: SUNPHARMA) is in advanced negotiations to acquire Organon & Co. (NYSE: OGN), a global leader in women's health, for a reported $12 billion, according to sources familiar with the matter. The potential deal marks a significant strategic move by India's largest drugmaker to expand its footprint in the high-value specialty pharmaceuticals market.","og_url":"https:\/\/flcube.com\/?p=62962","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-04-13T05:44:41+00:00","article_modified_time":"2026-04-13T05:44:42+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=62962#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=62962"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Sun Pharma in Advanced Talks to Acquire Organon for $12 Billion, Bolstering Women&#8217;s Health Portfolio","datePublished":"2026-04-13T05:44:41+00:00","dateModified":"2026-04-13T05:44:42+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=62962"},"wordCount":401,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["NSE: SUNPHARMA","NYSE: OGN","Organon","Sun Pharmaceutical Industries"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=62962#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=62962","url":"https:\/\/flcube.com\/?p=62962","name":"Sun Pharma in Advanced Talks to Acquire Organon for $12 Billion, Bolstering Women's Health Portfolio - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-04-13T05:44:41+00:00","dateModified":"2026-04-13T05:44:42+00:00","description":"Sun Pharmaceutical Industries Ltd. (NSE: SUNPHARMA) is in advanced negotiations to acquire Organon & Co. (NYSE: OGN), a global leader in women's health, for a reported $12 billion, according to sources familiar with the matter. The potential deal marks a significant strategic move by India's largest drugmaker to expand its footprint in the high-value specialty pharmaceuticals market.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=62962#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=62962"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=62962#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Sun Pharma in Advanced Talks to Acquire Organon for $12 Billion, Bolstering Women&#8217;s Health Portfolio"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/62962","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=62962"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/62962\/revisions"}],"predecessor-version":[{"id":62963,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/62962\/revisions\/62963"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=62962"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=62962"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=62962"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}